Pioneering cancer plasticity atlas will help predict response to cancer therapies
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
On May 19, 2025, researchers from the Karlsruhe Institute of Technology (KIT) announced they have have discovered how…
On Dec. 27, 2024, BioNTech announced it had entered into two separate settlement agreements with the U.S. National…
On Nov. 15, 2024, an international research team including scientists from the Max Planck Institute reported that critical…
On Nov. 11, 2024, an international team of researchers has for the first time cured patients with Toxic…
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
On Oct. 8, 2024, researchers from the Max Planck Institute for Plant Breeding announced they have developed a…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Aug. 28, 2024, the University of Würzburg announced research using newly generated “optogenetic” tobacco plants to investigated…
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…
On Jul. 25, 2024, the World Health Organization (WHO) announced during the 25th International AIDS Conference, being held…
On Jul. 15, 2024, Colorado Parks and Wildlife officials announced the first finding of ‘rustrela virus’ in a…
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
On Mar. 5, 2024, the World Health Organization (WHO) announced that in February 2024, Austria, Denmark, Germany, Sweden…
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the first over-the-counter (OTC)…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Jul. 28, 2023, researchers from the Institute of Zoology at the University of Cologne, the Max Planck…
On Jun. 20, 2023, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Jardiance (empagliflozin) and Synjardy…
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Riss, Germany….
On Mar. 20, 2023, National Institutes of Health (NIH) scientists announced that the magnitude and quality of a…
On Mar. 14, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
On Mar. 1, 2023, BioNTech and Pfizer announced that they had submitted an application to the U.S. Food…
On Dec. 5, 2022, Pfizer and BioNTech announced that the companies had submitted an application to the U.S….
On Nov. 18, 2022, Pfizer and BioNTech announced results from an analysis examining the immune response induced by…
On Nov. 16, 2022, Pfizer and BioNTech announced that the companies have initiated a Phase 1 study to…
On Nov. 10, 2022, Pfizer and BioNTech announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…